Knife River Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Knife River Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.15B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.90B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $2.83B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $2.53B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $2.23B | Feb 27, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.83B | Feb 27, 2024 |
| FY2023 | Dec 31, 2022 | $2.53B | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $2.23B | Feb 27, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $577.33M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $569.83M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $538.94M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $360.89M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $346.95M | Feb 27, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $157.07M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $201.68M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $182.87M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $116.22M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $129.76M | Feb 27, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $285.87M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $316.19M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $296.40M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $194.30M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $191.08M | Feb 27, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $291.46M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $253.64M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $242.54M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $166.60M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $155.87M | Feb 27, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $278.48M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $322.32M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $335.73M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $207.44M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $181.24M | Feb 27, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.65B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.85B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $2.60B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $2.29B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $2.18B | Feb 27, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.01B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.38B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $1.33B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.27B | Feb 27, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.64B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.48B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.27B | Feb 20, 2026 |
| FY2025 | Dec 31, 2022 | $1.03B | Feb 20, 2026 |
| FY2024 | Dec 31, 2021 | $952.84M | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $878.24M | Feb 27, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $519.67M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $297.23M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $274.48M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $274.54M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $276.43M | Feb 27, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.02B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $867.55M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $665.87M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $494.66M | Feb 27, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $73.82M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $236.80M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $219.32M | Feb 21, 2025 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $677.39M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $681.66M | Feb 21, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 27, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 27, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 56.66M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 56.61M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | 56.58M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 80,000 | Feb 27, 2024 |